Integrating genetic risk and AI‐ECG–derived features enhances AF prediction beyond an established clinical model, supporting the use of combined digital and genetic biomarkers for risk stratification.
Abstract
ABSTRACT Background Accurate prediction of atrial fibrillation (AF) is essential for prevention. The CHARGE‐AF score, based on routinely available clinical factors, provides a practical tool for estimating AF risk but has limited predictive accuracy. This study aimed to improve AF risk prediction by integrating artificial intelligence (AI)–based electrocardiogram (ECG) analysis of age and sex with genetic information in addition to established clinical risk factors. Methods We analyzed 39 478 UK Biobank participants without prior AF. A polygenic risk score for AF (AF‐PRS), the AI‐ECG age gap (AI‐ECG–predicted age minus chronological age), and AI‐ECG–predicted sex mismatch were evaluated on top of the CHARGE‐AF model. Model performance was compared across sequential prediction models. Results Over a median follow‐up of 2.7 years (interquartile range, 1.7–4.2; maximum, 6.7), 533 participants (1.3%) developed AF. AF‐PRS (HR 1.61, 95% CI: 1.48–1.76) and the AI‐ECG age gap (HR 1.37, 95% CI: 1.24–1.51) were independently associated with incident AF. Compared with CHARGE‐AF alone (C‐index 0.708, 95% CI: 0.686–0.730), adding AF‐PRS improved discrimination (C‐index 0.743; Δ0.035, 95% CI: 0.021–0.049; p < 0.001). Adding traditional ECG parameters did not enhance performance, whereas incorporating AI‐ECG features (age gap and sex mismatch) into the combined clinical and genetic model provided additional gain in discrimination (C‐index 0.754; Δ0.045, 95% CI: 0.028–0.062), reclassification (net reclassification improvement 0.408), and discrimination improvement (0.007; all p < 0.001). Conclusions Integrating genetic risk and AI‐ECG–derived features enhances AF prediction beyond an established clinical model, supporting the use of combined digital and genetic biomarkers for risk stratification.
External validation of the GLORIA-AF Stroke Weighted Risk Score supports its transportability and potential adjunctive role in guideline-directed thromboembolic risk assessment and generally greater net benefit than CHA2DS2-VA.
Combining the three ECG-derived biomarkers showed complementary predictive value and improved discrimination by up to 10% over age alone in individuals aged <75 years, and when combined with age, improved predictive performance compared with age alone.
Lisa Attali, Yosef Solewicz, Shany Brimer Biton et al.· Physiological Measurement· 0 citations
Artificial intelligence-enabled electrocardiogram interpretation shows strongest support for arrhythmia detection and automated ECG classification, while structural disease screening and prognostic modeling remain promising but less mature.
Mohamed Elhussain, Esra M. Abdalla, Ragda Ali et al.· BMC Cardiovascular Disorders· 0 citations
Abstract Aims Atrial fibrillation (AF) is associated with an increased risk of stroke, yet no evidence exists on the collective effect of electrocardiogram (ECG) risk factors in early detection of AF. We aimed to evaluate the risk of new-onset AF and stroke according to specific ECG risk factors to identify patients at...
C. Binding, C. Polcwiartek, K. Kragholm et al.· European Heart Journal Open· 0 citations